background: Endometriosis is a disease known to be detrimental to fertility. Women with endometriosis, and the presence of endometrioma, may require artificial reproductive techniques (ART) to achieve a pregnancy. The specific impact of endometrioma alone and the impact of surgical intervention for endometrioma on the reproductive outcome of women undergoing IVF/ICSI are areas that require further clarification. The objectives of this review were as follows: (i) to determine the impact of endometrioma on IVF/ICSI outcomes, (ii) to determine the impact of surgery for endometrioma on IVF/ICSI outcome and (iii) to determine the effect of different surgical techniques on IVF/ICSI outcomes.
Introduction
Endometriosis is a disease known to be detrimental to fertility (Giudice and Kao, 2004; Farquhar, 2007; Holoch and Lessey, 2010) . A significant number of women with endometriosis will eventually seek ART, namely in vitro fertilization (IVF) with or without intra-cytoplasmic sperm injection (ICSI) for conception. Between 17 and 44% of women with endometriosis will have endometrioma (Jenkins et al., 1986; Redwine, 1999) . The exact pathophysiology of endometrioma related to infertility is still unknown. It can be detrimental to fertility directly by distorting tubo-ovarian anatomy (Young et al., 2013) , or indirectly by invoking inflammatory (Gazvani and Templeton, 2002; Iwabe et al., 2002) and oxidative damage (Matsuzaki and Schubert, 2010; Agarwal et al., 2012) on the oocytes resulting in poorer quality oocytes (Gupta et al., 2006) . Our group and others have shown that the presence of endometriosis does not adversely affect IVF outcomes in terms of live birth, even though women with endometriosis have lower oocytes yield per cycle compared with those without endometriosis (Barnhart et al., 2002; Harb et al., 2013; Hamdan et al., 2015) . The latter finding is somewhat counterintuitive given that pregnancy rate increases proportionately with the number of oocytes collected until a threshold (Sunkara et al., 2011; Ji et al., 2013) . The impact of endometriosis is likely to be more profound in those with reduced ovarian reserve although this has not been specifically investigated. Furthermore, the differential impact of the presence or absence of endometrioma was not specifically examined in the abovementioned studies.
There is now molecular, histological and morphological evidence to suggest that endometriosis is detrimental to the ovaries (Sanchez et al., 2014) . Toxic content from an endometrioma may lead to unfavourable events such as increased oxidative stress, increase fibrosis, loss of cortex specific stroma, smooth muscle cell metaplasia, vascularization defect and, later, reduced follicular maturation. Whether this vicious cycle of damage can be ameliorated by surgical treatment or IVF/ICSI is still controversial.
Surgical treatment of endometriosis and endometrioma prior to IVF/ICSI is widely practiced (Vercellini et al., 2009 ) even though very little evidence exists to provide robust guidance to clinicians (Dunselman et al., 2014) . More recent studies have generated some concern that the surgical treatment on endometrioma could be detrimental to ovarian reserve (Raffi et al., 2012; Somigliana et al., 2012; Muzii et al., 2014) and subsequently adversely affect IVF/ICSI reproductive outcomes (Tsoumpou et al., 2009; Benschop et al., 2010) . The possible adverse outcomes associated with the presence of endometrioma during IVF/ ICSI have also not been studied. The risks of surgery and its potential damage to ovarian reserve have to be balanced with the complications associated with the persistence of the endometrioma during IVF/ICSI (Fig. 1 ). As such, this area of management often poses a clinical conundrum for health care practitioners.
The specific impact of endometrioma alone, the differential influences of the disease entity (that of endometrioma rather than endometriosis per se) and the impact of surgical intervention of endometriosis on the reproductive outcome of women undergoing IVF/ICSI are areas that require further clarification. To this end, we performed a systematic review and meta-analysis with the following objectives: (i) to determine the impact of endometrioma on IVF/ICSI outcomes, (ii) to determine the impact of surgery for endometrioma on IVF/ICSI outcomes and (iii) to determine the effect of different surgical techniques on IVF/ICSI outcomes. The primary outcome was live birth rate (LBR); the secondary outcomes were clinical pregnancy rate (CPR), miscarriage rate (MR), mean number of oocyte retrieved (MNOR) and rates of any adverse effects such as cancellation and associated complications during the IVF/ICSI treatment.
Methods

Criteria for considering studies for this review
Type of studies
Published cohort or case -control studies (retrospective or prospective) and randomized controlled trials were eligible for inclusion. Where studies reported similar or overlapping data, only the latest or those with the largest dataset were considered for this review.
Type of participants
The included studies had: (i) women who underwent IVF/ICSI, (ii) a study group of women with the presence of identified endometrioma and (iii) a control group. Studies that satisfied the above criteria were included whether or not the participants had prior surgical treatment for their endometrioma. The diagnosis of endometrioma could be by laparoscopy or imaging modalities. Studies were excluded if: (i) the participants had ovarian cysts other than endometrioma, (ii) the participants had received any known non-surgical treatment (medical management, alternative treatment) prior to IVF/ICSI, (iii) the participants were involved with donor/recipient oocytes treatment or (iv) an appropriate control group was not included. We considered appropriate control groups to be: (i) women who underwent IVF/ICSI for indications not related to endometriosis, (ii) women with endometriosis in the absence of endometrioma or (iii) women with endometrioma that was left untreated, (iv) women who had endometrioma treated by different surgical techniques.
Type of interventions
Surgical treatment for endometriomas includes drainage of the endometrioma without removal of the cyst wall, with or without coagulation of the cyst wall (laparoscopic or transvaginal ultrasound guided), or cystectomy with drainage and/or excision/stripping of the cyst wall (by laparoscopy/ laparotomy or both). Aspiration of endometrioma during oocyte retrieval was not considered an operative surgical treatment prior to IVF/ICSI.
We included participants who either underwent IVF or ICSI or both. We excluded participants who underwent gamete intra-fallopian transfer or in vitro maturation.
Type of outcome measures
The primary outcome measure was LBR per woman, defined as the number of deliveries that resulted in at least 1 live born baby expressed per 100 patients.
Secondary outcome measures were as follows: (i) CPR per woman, defined as pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy and was expressed per 100 patients (Zegers-Hochschild et al., 2009) , (ii) mean number of oocytes retrieved per cycle, (iii) MR, (iv) fertilization rate, (v) implantation rate, (vi) rates of adverse outcomes including cycle cancellation and surgical complications such as infection, bleeding or pain during IVF/ICSI. Where available, comparison was also made between participants' characteristics of ovarian reserve: antral follicle count (AFC), follicle stimulating hormone (FSH) and anti-mullerian hormones (AMH).
Search methods for identification of studies
We searched all published and unpublished studies from January 1980 to December 2014 on surgical treatment of endometrioma and IVF/ICSI outcomes, without language restriction and in consultation with a search methodologist.
Electronic searches
The following electronic databases, trial registers and websites were searched: MEDLINE, EMBASE, Cochrane Central register of Controlled Trials, and Web of Science. A search strategy was carried out based on the following keywords and/or medical subject heading (MeSH) terminology: IVF/ICSI, endometriosis, endometrioma, IVF, ICSI, in vitro fertilization, ICSI, outcome, pregnancy and live birth.
Searching other resources
Reference lists of all primary and review articles were hand searched, and experts in the field were contacted to obtain additional articles not captured in the electronic searches. Relevant journals and conference abstracts that were not covered in the databases were also hand searched.
Data collection and analysis
Selection of studies
After a primary screen of all titles and abstracts retrieved (by M.H.), the full texts of all potentially eligible studies were retrieved. Two review authors Impact of endometrioma on IVF/ICSI outcomes (M.H., Y.C.) independently examined these articles for compliance with the inclusion criteria and selected the studies that were eligible for inclusion in the review. Study investigators were contacted if clarification was needed for study eligibility. Disagreement as to study eligibility was resolved after discussion by both reviewers. The process is documented in the PRISMA chart (Fig. 2) .
Data extraction and management
Two review authors independently extracted the data using a data extraction form designed and pilot-tested by the authors on two independent occasions. Any disagreements were resolved by discussion between both review authors. Data retrieved included study characteristics and their various outcomes data. Both reviewers counterchecked these extracted data repeatedly. Where studies had multiple publications or were using the same database, the latest and main trial report was used as the reference and the additional details were scanned from the secondary or earlier papers. Authors were contacted for further data and/or results, as required. All the available data were extracted into Review Manager 5 for further analysis.
Comparative analysis
Analyses were performed in studies where IVF/ICSI outcomes in women with intact endometrioma during IVF/ICSI were compared with those with no endometriosis or those with peritoneal endometriosis.
IVF/ICSI outcomes after surgical treatment for endometrioma were compared with those where the women had untreated endometrioma, peritoneal endometriosis or a normal unaffected contralateral ovary.
We also performed a head-to-head comparison of different ovarian cystectomy surgical techniques including laparoscopic or transvaginal aspiration and different laparoscopic cystectomy techniques.
Assessment of heterogeneity
We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta-analysis to provide a clinically meaningful summary. Statistical heterogeneity was evaluated by the measure of the I inconsistencies depend on several factors. Scores below 50% were considered to represent low or moderate heterogeneity whereas, I 2 equal to or greater than 50% was taken to indicate substantial heterogeneity and, in that case, a random-effects analysis was used. Incorporation of a random-effects meta-analysis model involves an assumption that the effects being estimated in the different studies are not identical but follow some distribution. Sensitivity analyses were not performed. Where there were at least 10 studies in our comparative analysis, we also generated funnel plots for comparison to inspect for small study effects.
Data synthesis
Quality assessment of the data Two authors (M.H., Y.C.) assessed the methodological quality of the studies and extracted relevant data such as diagnosis of endometriosis, surgical treatment, staging of the disease, selection of controls and definition of primary and secondary outcomes. Where available, we extracted statistical data from the original papers or calculated missing parameters by using data provided. The quality of individual studies was assessed in accordance with the MOOSE criteria and the Newcastle-Ottawa Scale (Wells et al., 2010) . By using the Newcastle-Ottawa scale, non-randomized studies were rated according to eight items categorized in three domains: study group selection, comparability of the groups and ascertainment of outcome (maximum scores of 4, 2 and 3, respectively). Scores were represented with stars for each quality item to provide a visual assessment. Studies were awarded up to nine stars if they fulfilled all the quality items. Randomized controlled trials were assessed on the risk of methodological bias (Higgins JPT, 2011).
Measures of treatment effects
For dichotomous data (e.g. CPR), the numbers of events in the control and intervention groups of each study were keyed into Review Manager 5 and analysed using Mantel-Hansel odds ratio (OR). For continuous data, standardized mean differences (SMD) between treatments groups were calculated.
Results
Result of search
The search strategy yielded 913 studies; however, 845 studies were excluded because it was clear from the title or abstract that they did not fulfil the selection criteria. Out of 68 potential studies for the analysis, we further excluded 16 studies that had no relevant comparisons (non-endometrioma), 13 studies that had no available control groups and 6 publications that were reviews (Gupta et al., 2006; Somigliana et al., 2006; Vercellini et al., 2009; Tsoumpou et al., 2009; Benschop et al., 2010; Gelbaya and Nardo, 2011) . A final number of 33 studies were included for the meta-analysis.
Description of studies and participants
The majority of the included studies (Table I) were non-RCT (Nargund et al., 1996; Yanushpolsky et al., 1998; Diaz et al., 2000; Tinkanen and Kujansuu, 2000; Canis et al., 2001; Ho et al., 2002; Marconi et al., 2002; Suganuma et al., 2002; Takuma et al., 2002; Wu et al., 2003; Wyns and Donnez, 2003; Garcia-Velasco et al., 2004; Wong et al., 2004; Loo et al., 2005; Ragni et al., 2005; Suzuki et al., 2005; Esinler et al., 2006; Yazbeck et al., 2006; Duru et al., 2007; Matalliotakis et al., 2007; Nakagawa et al., 2007; Somigliana et al., 2008; Kuroda et al., 2009; Yamamoto et al., 2009; Barri et al., 2010; Almog et al., 2011; Bongioanni et al., 2011; Takashima et al., 2013; Takebayashi et al., 2013; Lee et al., 2014) (n ¼ 30) and the remaining studies (n ¼ 3) were RCTs (Pabuccu et al., 2004; Demirol et al., 2006; Pabuccu et al., 2007) . There were 30 studies that included women with endometriosis who had surgical treatment to their endometrioma prior to IVF/ICSI; 12 studies included more than one comparative group and 13 studies included women with intact endometrioma (either as a study or control group). From the included studies, 18 indicated the laterality of the disease (bilateral disease n ¼ 2/18, unilateral disease n ¼ 6/18, and unilateral and/or bilateral n ¼ 10/18). Less than half (n ¼ 14) of the included studies specified the size of endometrioma as their inclusion criteria, and the sizes ranged from 1 cm or more to size of .6 cm. There were 19 other studies that did not specify the size of the endometrioma (Table I ). All studies except one (Barri et al., 2010) stated the stimulation protocol: long protocol (n ¼ 28/33), mixed protocols (n ¼ 3/33) or short agonist protocol (1/33). Women in the majority of the studies underwent ovarian cystectomy (n ¼ 27), either by laparoscopy (25/27) or by laparoscopy and/or laparotomy (2/27), whereas in three studies some women had transvaginal cyst aspiration.
In five studies where women with endometrioma had no surgical treatment, the comparative controls included women with no endometriosis. Studies examining the outcome of surgical treatment in women with endometriomas included various comparative control groups: (i) untreated endometrioma (n ¼ 11), (ii) endometriosis with no previous endometrioma (n ¼ 7), (iii) tubal factor (n ¼ 10) and (iv) normal contralateral ovary (n ¼ 4). Three studies compared ovarian cystectomy with transvaginal aspiration prior to IVF/ICSI whereas three other studies made head-to-head comparisons of different ovarian cystectomy surgical techniques.
Amongst all the included studies, reported outcomes were as follows: LBR (11/33), CPR (29/33), MNOR (33/33), MR (9/33), implantation rate (14/33), fertilization rate (19/33), FSH dose requirement (17/33), cycle cancellation rate (7/33), baseline characteristics of baseline FSH level (14/33) and AFC (7/33). None of the included studies reported baseline characteristics of AMH levels or any clinical adverse outcomes related to infection, bleeding or pain. Papers that reported IR and FR have presented the data in percentages and none provide the raw data. None of the studies exclusively examined women with recurrent endometrioma although some (Tinkanen and Kujansuu, 2000; Wong et al., 2004; Barri et al., 2010) included women with endometrioma who had prior surgical treatment.
Quality assessment of studies
Systematic risk assessment of methodological bias (Higgins JPT, 2011) of the three included RCTs revealed all studies to have a high risk of reporting bias (Pabuccu et al., 2004; Demirol et al., 2006; Pabuccu et al., 2007) and two studies (Pabuccu et al., 2004; Demirol et al., 2006) to have a risk of blinding bias (Table II) . By assessment using the NOS (Wells et al., 2010) , the majority of the non-randomized studies were awarded with eight stars whereas two studies were awarded nine stars, the highest possible score (Table III) . (Fig. 3a and b) . Baseline FSH levels in women with endometrioma were higher when compared with women with no endometriosis (SMD 0.20 Fig. 5a and b) . Women with endometrioma who had surgical treatment had a lower AFC (SMD 20.53 [20.88, 20.18 
Impact of endometrioma without intervention on IVF/ICSI outcomes
Different laparoscopic cystectomy surgical techniques
We found three studies comparing the effect of different laparoscopic surgical techniques to IVF outcomes. One study (Takebayashi et al., 2013) compared the conventional laparoscopic cystectomy technique to the laser ablation technique; the authors reported no difference in pregnancy rates and MNOR. Another study examined different haemostatic techniques following laparoscopic cystectomy between coagulation and suture and reported no difference in pregnancy rate; however, the authors only reported the number of oocytes retrieved from the treated ovary compared with the contralateral ovary without disease. An earlier study (Takuma et al., 2002) examined four different techniques namely laparoscopic cystectomy, laparoscopic aspiration and sclerotherapy, and laparoscopic aspiration with and without coagulation. They found no differences in the MNOR but a higher pregnancy rate in the group that had laparoscopic aspiration with coagulation of the cyst wall. None of the studies reported adverse outcomes during IVF/ICSI. Meta-analysis of these available data was not possible as the comparison groups were not similar.
Discussion
We found a similar LBR, CPR and MR, but a lower mean number of oocytes retrieved in women with intact endometrioma when compared with women without endometrioma. Women with endometrioma, however, were nearly three times as likely to have a cancelled cycle compared with those without the disease. Amongst those with endometrioma, women who had surgical treatment prior to IVF/ICSI had similar LBR, CPR, MNOR and MR compared with those women with intact endometrioma. However, these women had a lower AFC and required a higher total gonadotrophin stimulation dose compared with those who had no surgery (Fig. 6 ). Our previous publication (Hamdan et al., 2015) concluded that women with more severe endometriosis (Stage III and Stage IV) had a poorer reproductive outcomes. Severe endometriosis exists in varied forms and is a rather heterogeneous group (Burney and Giudice, 2012) . In this review, we have exclusively examined a defined group of women with endometrioma that would inevitably overlap with those categorized at stage III/IV endometriosis. The observation of poorer reproductive outcomes of stage III and IV endometriosis overall but not of endometrioma on its own suggests that endometrioma alone is unlikely to be the major contributory cause, at least in the context of IVF/ICSI. The poorer reproductive outcomes with severe disease may be more closely linked with factors such as the non-ovarian aspects of the disease entity, the presence or absence of surgical interventions and the baseline ovarian reserve.
The diminished number of oocytes retrieved and the higher baseline levels of FSH in women with endometrioma compared with women with no endometriosis allows speculation that the ovarian endometriotic disease per se exerts some detrimental impact on the ovary. The impact of the disease may not be solely on diminished oocyte numbers but more importantly on oocyte quality, with supportive evidence drawn from oocyte donor recipient studies where recipients of oocyte donors with endometriosis achieved lower pregnancy rates than those who received oocytes from non-endometriosis donors (Diaz et al., 2000 Impact of endometrioma on IVF/ICSI outcomes studies have found the peritoneal (Young et al., 2013) and follicular environment (Oral et al., 1996) of women with endometriosis to be hostile to the integrity and intrinsic functions of the oocyte (Da Broi et al., 2014) and subsequent embryo development (Sanchez et al., 2014) . However, other studies examining the basic morphology of oocytes and embryo development in women with and without endometriosis have not found any differences in the two groups (Suzuki et al., 2005; Reinblatt et al., 2011; Ashrafi et al., 2014; Filippi et al., 2014) . There were no embryo development data that we could utilize in this review for comparison. The question that has arisen but is yet unanswered is whether treatment, be it medical or surgical, should be established at the earliest opportunity to reduce the adverse impact of the disease on the ovary. Given that the diagnosis of endometriosis is often delayed (Ballard et al., 2010; Hudelist et al., 2012; Nnoaham et al., 2012) , there is a clear need for more effective noninvasive diagnostic clinical tools, and innovative fertility preserving treatments for this condition.
There is no doubt, as revealed by this study and studies on ovarian reserve markers by others, that surgery on endometrioma has a detrimental impact on ovarian reserve (Raffi et al., 2012; Somigliana et al., 2012; Muzii et al., 2014) . Arguably, the most reliable data where conclusions can be drawn would be those relating specifically to women with bilateral endometriomas; however, it is not possible to extrapolate such data from the current available published studies. The physiological functional compensation of one ovary in the presence of a compromised contralateral ovary, coupled with the use of stronger gonadotrophin ovarian stimulation, as shown by the higher dose of FSH required for ovarian stimulation in women who had surgery prior to their IVF/ICSI, may well account for the observation that surgery did not have any apparent impact on the LBR. However, such compensatory mechanisms may not be present in those already with a lower ovarian reserve, where an even lower than usual cumulative LBR may be pre-empted given the additive impact of lower oocyte yield in these patients and the presumptive effect on reducing the number of embryos potentially available for frozen embryo transfers. Hence, the presence of endometrioma would be a justifiable indication for the assessment of ovarian reserve prior to surgery even in the younger patients. It is hence important to consider individualizing the care of women with endometrioma prior to IVF/ICSI, adopting a more conservative approach in those who are asymptomatic, are older or have established low ovarian reserve. The advantages of pituitary down-regulation prior to IVF/ICSI may in this case be helpful (Sallam et al., 2006) .
Our study has highlighted the lack of clinical studies examining the complications associated with the surgical treatment of endometrioma (Dunselman et al., 2014) and the complication rate during the course Impact of endometrioma on IVF/ICSI outcomes of the IVF treatment and ovum pickup such as pain, infection or fever. The exact reasons for the high IVF cancellation rate in women with endometrioma compared with those without the disease as found in this study are yet to be determined and could be attributed by chance. However, we wish to highlight the paucity of the data available for analysis and recommended that future studies include outcome measures, which examine adverse events including cancellation rates as such events forms crucial aspects of our patients' IVF/ICSI journey, and such information will help in the counselling process.
Due to the heterogeneity of data, we are unable to evaluate the reproductive outcomes pertaining to the size of the endometrioma. The endometrioma size and the patients' symptoms in addition to the accessibility of the ovaries for oocyte retrieval are also logical reasons to justify the consideration for their removal prior to IVF/ICSI. The latter recommendation is in line with the recent ESHRE guidance on the management of the condition (Dunselman et al., 2014) .
As with many other meta-analyses, our study may be confounded by the high clinical heterogeneity of the included studies, as inevitably, studies brought together in a systematic review will differ. The majority, with the exception of three studies, were all not randomized controlled trials. Some of the comparisons were only based on non-randomized studies and therefore will limit the robustness of the findings. Of relevance however, whilst the Newcastle -Ottawa Scoring assessment provided a means to assess non-randomized studies, the scoring system itself is not without its drawbacks and criticisms (Stang, 2010) . Additionally, the primary outcome of the comparison between women with treated versus intact endometriomas before IVF/ICSI was based on only 5 of the 33 considered studies, and only one was an RCT. We note that differences identified from analysis of too few studies can be due to chance and also are subjected to confounders such as age and body mass index. Overall, the conclusions drawn from this review represents a current collation of best evidence. 
Conclusion
Compared with women without the disease, women with endometrioma have a similar LBR, CPR and MR although they have a lower mean number of oocyte retrieved, require higher FSH dosage for ovarian stimulation and have a lower AFC, suggesting that their ovarian reserve is diminished prior to IVF/ICSI. Women with endometrioma should be counselled regarding their increased risk of cycle cancellation. Whilst surgery did not seem to influence the LBR, surgical treatment of endometrioma prior to IVF/ICSI could exert a further detrimental impact on ovarian reserve. There is therefore not one dogmatic recommendation as to whether women with endometrioma should or should not have surgical intervention prior to IVF/ICSI, but based on current evidence, consideration should be given to individualize the care of these patients.
